The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial

The Efficacy and Mechanism Evaluation of Treating Idiopathic Pulmonary fibrosis with the Addition of Co-trimoxazole (EME-TIPAC): study protocol for a randomised controlled trial

Abstract Background We hypothesise, based upon the findings from our previous trial, that the addition of co-trimoxazole to standard therapy is beneficial to patients with moderate to severe idiopathic pulmonary fibrosis (IPF). We aim to investigate this by assessing unplanned hospitalisation-free s...

Full description

Bibliographic Details
Main Authors: Matthew Hammond, Allan B. Clark, Anthony P. Cahn, Edwin R. Chilvers, William Duncan Fraser, David M. Livermore, Toby M. Maher, Helen Parfrey, Ann Marie Swart, Susan Stirling, David Thickett, Moira Whyte, Andrew Wilson
Format: Article
Language:English
Published: BMC 2018-02-01
Series:Trials
Subjects:
Idiopathic pulmonary fibrosis
Co-trimoxazole
Forced vital capacity
Mortality
Online Access:http://link.springer.com/article/10.1186/s13063-018-2453-6

Internet

http://link.springer.com/article/10.1186/s13063-018-2453-6

Similar Items